Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

228.82 +9.40 (+4.28%)
Streaming Delayed Price Updated: 2:12 PM EDT, Jun 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Bio-Rad Reports Third-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Earnings Outlook For Bio-Rad Laboratories
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
Via Investor Brand Network
The Latest Analyst Ratings for Bio-Rad Laboratories
Via Benzinga
The Latest Analyst Ratings for Bio-Rad Laboratories
Via Benzinga
Death Cross Looms Over Bio-Rad Laboratories Investors
Via Benzinga
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs. 
Via InvestorPlace
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Second-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
From Bio-Rad Laboratories, Inc.
Via Business Wire
Recap: Bio-Rad Laboratories Q1 Earnings
Via Benzinga
Golden Cross Appears Before Bio-Rad Laboratories Investors
Via Benzinga
Why Are velo Biosciences Stock Is Trading Higher Today?
Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO). 
Via Benzinga
Bio-Rad Announces New Share Repurchase Program
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Publishes Corporate Sustainability Report for 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Stocks Roar Back To Life; Still Pacing For Weekly Loss
Rebounding bank stocks, stellar Apple earnings, and a blowout jobs report are all helping stocks move significantly higher Friday afternoon. 
Via Talk Markets
Bio-Rad Reports First-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
The 3 Most Promising Biotech Stocks to Buy Now
With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now. 
Via InvestorPlace
I Asked ChatGPT for 10 EV Stocks to Buy. Here’s What It Recommended.
What are the best EV stocks to buy? ChatGPT has different answers, depending on how it is asked. Here's what investors need to know. 
Via InvestorPlace
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.